Evidence map›Paper›PMID 27582418›Full record

ArticleStem cell investigation2016

Arid1a controls tissue regeneration.

Shuai Wu, Rugang Zhang, Benjamin G Bitler

Open access · hybridAbstract readCommentEditorial
In one paragraph

Article in Stem cell investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Cancers · 2024
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shuai WuGene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA 19104, USA.
Rugang ZhangGene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA 19104, USA.
Benjamin G BitlerGene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA 19104, USA.
The Wistar Institute · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Nan Zhang · 1985 to 2026
$75.9M
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancerR01CA202919 · NCI · WISTAR INSTITUTE · PI Xi Chen, Rugang Zhang · 2016 to 2026
$4.1M
Targeting EZH2 in CARM1-expressing epithelial ovarian cancerR01CA163377 · NCI · WISTAR INSTITUTE · PI ZHANG, RUGANG · 2012 to 2021
$3.7M
Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancerK99CA194318 · NCI · WISTAR INSTITUTE · PI BITLER, BENJAMIN G · 2015 to 2016
$230k
NCI NIH HHS K99 CA194318NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA163377NCI NIH HHS R01 CA202919
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27582418
PMCPMC4981703
OpenAlexW2488844669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.